These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22899870)

  • 1. Resistant hypertension and the neglected antihypertensive: sodium restriction.
    Agarwal R
    Nephrol Dial Transplant; 2012 Nov; 27(11):4041-5. PubMed ID: 22899870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistant hypertension: an overview of evaluation and treatment.
    Sarafidis PA; Bakris GL
    J Am Coll Cardiol; 2008 Nov; 52(22):1749-57. PubMed ID: 19022154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RGS2 expression and aldosterone: renin ratio modulate response to drug therapy in hypertensive patients.
    Semplicini A; Strapazzon G; Papparella I; Sartori M; Realdi A; Macchini L; Calò LA; Ceolotto G
    J Hypertens; 2010 May; 28(5):1104-8. PubMed ID: 20375904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent update in the management of hypertension.
    Lim S
    Acta Med Indones; 2007; 39(4):186-91. PubMed ID: 18380058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resistant hypertension].
    Feldstein CA
    Rev Med Chil; 2008 Apr; 136(4):528-38. PubMed ID: 18769797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
    Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
    Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of resistant hypertension].
    Briet M; Bobrie G; Azizi M
    Rev Prat; 2013 May; 63(5):681-8. PubMed ID: 23789498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistant hypertension, secondary hypertension, and hypertensive crises: diagnostic evaluation and treatment.
    Acelajado MC; Calhoun DA
    Cardiol Clin; 2010 Nov; 28(4):639-54. PubMed ID: 20937447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment resistant hypertension.
    Bolli P
    Am J Ther; 2008; 15(4):351-5. PubMed ID: 18645339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of dietary modifications on the blood pressure response to antihypertensive medication.
    Huggins CE; Margerison C; Worsley A; Nowson CA
    Br J Nutr; 2011 Jan; 105(2):248-55. PubMed ID: 20807467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting.
    McAdam-Marx C; Ye X; Sung JC; Brixner DI; Kahler KH
    Clin Ther; 2009 May; 31(5):1116-23. PubMed ID: 19539112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and management of the patient with difficult-to-control or resistant hypertension.
    Viera AJ; Hinderliter AL
    Am Fam Physician; 2009 May; 79(10):863-9. PubMed ID: 19496385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Underestimated frequency of resistant hypertension in predialysis nondiabetic patients].
    Prkacin I; Balenović D; Prkacin P; Jurina A; Santek L; Kasumović D; Cavrić G; Bulum T
    Acta Med Croatica; 2012 Jul; 66(3):229-33. PubMed ID: 23441538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased sodium intake correlates with greater use of antihypertensive agents by subjects with chronic kidney disease.
    Boudville N; Ward S; Benaroia M; House AA
    Am J Hypertens; 2005 Oct; 18(10):1300-5. PubMed ID: 16202852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and pharmacologic approach to patients with resistant hypertension.
    Adams M; Bellone JM; Wright BM; Rutecki GW
    Postgrad Med; 2012 Jan; 124(1):74-82. PubMed ID: 22314117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.